Global cancer statistics, CA: A Cancer Journal for Clinicians, vol.82, issue.19 suppl, pp.6169-90, 2011. ,
DOI : 10.3322/caac.20107
Metastatic colorectal cancer-past, progress and future, World Journal of Gastroenterology, vol.13, issue.28, pp.3806-3815, 2007. ,
DOI : 10.3748/wjg.v13.i28.3806
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4611212
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer, New England Journal of Medicine, vol.351, issue.4, pp.337-345, 2004. ,
DOI : 10.1056/NEJMoa033025
Cetuximab for the Treatment of Colorectal Cancer, New England Journal of Medicine, vol.357, issue.20, pp.3572040-2048, 2007. ,
DOI : 10.1056/NEJMoa071834
Open-Label Phase III Trial of Panitumumab Plus Best Supportive Care Compared With Best Supportive Care Alone in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer, Journal of Clinical Oncology, vol.25, issue.13, pp.251658-1664, 2007. ,
DOI : 10.1200/JCO.2006.08.1620
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer, New England Journal of Medicine, vol.360, issue.14, pp.3601408-1417, 2009. ,
DOI : 10.1056/NEJMoa0805019
Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer, Journal of Clinical Oncology, vol.27, issue.5, pp.663-671, 2009. ,
DOI : 10.1200/JCO.2008.20.8397
Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study, Journal of Clinical Oncology, vol.28, issue.31, pp.284697-4705, 2010. ,
DOI : 10.1200/JCO.2009.27.4860
Molecular determinants of anti-EGFR sensitivity and resistance in metastatic colorectal cancer, British Journal of Cancer, vol.25, issue.12, pp.1765-1772, 2010. ,
DOI : 10.1038/sj.bjc.6606008
Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer, Nature, vol.102, issue.7404, pp.486532-536 ,
DOI : 10.1038/nature11156
Molecular Mechanisms of Resistance to Cetuximab and Panitumumab in Colorectal Cancer, Journal of Clinical Oncology, vol.28, issue.7, pp.1254-1261, 2010. ,
DOI : 10.1200/JCO.2009.24.6116
Meyerson M: EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy, Science, issue.5676, pp.3041497-1500, 2004. ,
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non???Small-Cell Lung Cancer to Gefitinib, New England Journal of Medicine, vol.350, issue.21, pp.3502129-2139, 2004. ,
DOI : 10.1056/NEJMoa040938
Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study, The Lancet Oncology, vol.6, issue.5, pp.279-286, 2005. ,
DOI : 10.1016/S1470-2045(05)70102-9
Metastatic Colon Cancer, Journal of Clinical Oncology, vol.27, issue.35, pp.275924-5930, 2009. ,
DOI : 10.1200/JCO.2008.21.6796
URL : https://hal.archives-ouvertes.fr/hal-00618089
Epidermal Growth Factor Receptor (EGFR) gene copy number (GCN) correlates with clinical activity of irinotecan-cetuximab in K-RAS wild-type colorectal cancer: a fluorescence in situ (FISH) and chromogenic in situ hybridization (CISH) analysis, BMC Cancer, vol.26, issue.1, p.303, 2009. ,
DOI : 10.1200/JCO.2007.11.5022
Markers for EGFR pathway activation as predictor of outcome in metastatic colorectal cancer patients treated with or without cetuximab, European Journal of Cancer, vol.46, issue.11, pp.461997-2009, 2010. ,
DOI : 10.1016/j.ejca.2010.03.036
Mutation Status Predict Disease Control in Metastatic Colorectal Cancer Patients Treated With Cetuximab, Journal of Clinical Oncology, vol.25, issue.22, pp.253230-3237, 2007. ,
DOI : 10.1200/JCO.2006.10.5437
Tumour gene expression predicts response to cetuximab in patients with KRAS wild-type metastatic colorectal cancer, British Journal of Cancer, vol.9, issue.3, pp.488-495, 2011. ,
DOI : 10.1126/science.1073096
An A13 Repeat within the 3'-Untranslated Region of Epidermal Growth Factor Receptor (EGFR) Is Frequently Mutated in Microsatellite Instability Colon Cancers and Is Associated with Increased EGFR Expression, Cancer Research, vol.69, issue.19, pp.697811-7818, 2009. ,
DOI : 10.1158/0008-5472.CAN-09-0986
Performance of Different Microsatellite Marker Panels for Detection of Mismatch Repair-Deficient Colorectal Tumors, JNCI Journal of the National Cancer Institute, vol.99, issue.3 ,
DOI : 10.1093/jnci/djk033
Analysis of relative gene expression data using real-time quantitative PCR and the 2(?Delta Delta C(T)) Method, pp.402-408, 2001. ,
A sensitive assay for measuring SMN mRNA levels in peripheral blood and in muscle samples of patients affected with spinal muscular atrophy, European Journal of Human Genetics, vol.64, issue.10, pp.151054-1062, 2007. ,
DOI : 10.1016/S0022-510X(99)00325-1
Vienna RNA secondary structure server, Nucleic Acids Research, vol.31, issue.13, pp.313429-3431, 2003. ,
DOI : 10.1093/nar/gkg599
URL : http://doi.org/10.1093/nar/gkg599
Design, implementation and evaluation of a practical pseudoknot folding algorithm based on thermodynamics, BMC Bioinformatics, vol.5, issue.1, p.104, 2004. ,
DOI : 10.1186/1471-2105-5-104
CONTRAfold: RNA secondary structure prediction without physics-based models, Bioinformatics, vol.22, issue.14, pp.90-98, 2006. ,
DOI : 10.1093/bioinformatics/btl246
URL : http://ai.stanford.edu/~serafim/Publications/2006_CONTRAfold.pdf
CyloFold: secondary structure prediction including pseudoknots, Nucleic Acids Research, vol.38, issue.Web Server, pp.368-372 ,
DOI : 10.1093/nar/gkq432
URL : http://doi.org/10.1093/nar/gkq432
Down-regulation of Epidermal Growth Factor Receptor by Selective Expansion of a 5'-End Regulatory Dinucleotide Repeat in Colon Cancer with Microsatellite Instability, Clinical Cancer Research, vol.15, issue.14, pp.154531-4537, 2009. ,
DOI : 10.1158/1078-0432.CCR-08-1282
Somatic Deletions of the PolyA Tract in the 3??? Untranslated Region of Epidermal Growth Factor Receptor Are Common in Microsatellite Instability???High Endometrial and Colorectal Carcinomas, Archives of Pathology & Laboratory Medicine, vol.136, issue.5, pp.510-516 ,
DOI : 10.5858/arpa.2010-0638-OA
Pession A: T([20]) repeat in the 3?-untranslated region of the MT1X gene: a marker with high sensitivity and specificity to detect microsatellite instability in colorectal cancer, Int J Colorectal Dis, vol.2012, issue.275, pp.647-656 ,